Wiley Bros. Aintree Capital, LLC Johnson & Johnson Transaction History
Wiley Bros. Aintree Capital, LLC
- $14.9 Billion
- Q3 2025
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 663,276 shares of JNJ stock, worth $132 Million. This represents 0.83% of its overall portfolio holdings.
Number of Shares
663,276
Previous 604,758
9.68%
Holding current value
$132 Million
Previous $92.4 Million
33.13%
% of portfolio
0.83%
Previous 0.74%
Shares
30 transactions
Others Institutions Holding JNJ
# of Institutions
4,831Shares Held
1.74BCall Options Held
19.8MPut Options Held
16.8M-
Vanguard Group Inc Valley Forge, PA237MShares$47.2 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY198MShares$39.6 Billion0.67% of portfolio
-
State Street Corp Boston, MA132MShares$26.4 Billion0.88% of portfolio
-
Jpmorgan Chase & CO New York, NY58.6MShares$11.7 Billion0.72% of portfolio
-
Geode Capital Management, LLC Boston, MA56.2MShares$11.2 Billion0.69% of portfolio
About JOHNSON & JOHNSON
- Ticker JNJ
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,614,479,872
- Market Cap $522B
- Description
- Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...